Anne I. Boullerne

ORCID: 0000-0001-5364-1088
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Neurogenesis and neuroplasticity mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Nitric Oxide and Endothelin Effects
  • Neurology and Historical Studies
  • Systemic Lupus Erythematosus Research
  • History of Medicine Studies
  • RNA Research and Splicing
  • Axon Guidance and Neuronal Signaling
  • Genetic Neurodegenerative Diseases
  • History of Medical Practice
  • Systemic Sclerosis and Related Diseases
  • Peripheral Neuropathies and Disorders
  • Microtubule and mitosis dynamics
  • Immunotherapy and Immune Responses
  • Mitochondrial Function and Pathology
  • MicroRNA in disease regulation
  • RNA Interference and Gene Delivery
  • Mast cells and histamine
  • Wnt/β-catenin signaling in development and cancer
  • Health, Environment, Cognitive Aging
  • Hereditary Neurological Disorders
  • Immunotoxicology and immune responses
  • Salivary Gland Disorders and Functions
  • Powdery Mildew Fungal Diseases

University of Illinois Chicago
2015-2025

University of Leeds
2017

Université de Montréal
2017

John B. Pierce Laboratory
2017

Jesse Brown VA Medical Center
2009-2016

University of Chicago
2001-2004

Université de Bordeaux
1993-2002

University of Bonn
2002

Wayne State University
1999

Institute of Neurological Sciences
1997

Under pathological conditions, microglia produce proinflammatory mediators which contribute to neurologic damage, and whose levels can be modulated by endogenous factors including neurotransmitters such as norepinephrine (NE). We investigated the ability of NE suppress microglial activation, in particular its effects on induction activity inducible form nitric oxide synthase (NOS2) possible role that IL-1β plays response. Rat cortical were stimulated with bacterial lipopolysaccharide (LPS)...

10.1186/1742-2094-1-9 article EN cc-by Journal of Neuroinflammation 2004-01-01

Extracellular vesicles (EVs) are membrane nanovesicles of diverse sizes secreted by different cell types and involved in intercellular communication. EVs shuttle proteins, nucleic acids, lipids that reflect their cellular origin could mediate biological function recipient cells. circulate fluids considered as potential biomarkers be used to analyze characterize disease development, course response treatment. exhibit specific distribution glycolipids organization, but little is known about...

10.1002/jnr.23899 article EN Journal of Neuroscience Research 2016-08-25

Abstract Myelin repair is inhibited in multiple sclerosis (MS), ultimately leading to axonal damage and disability. We aimed understand the transcriptional mechanisms of regeneration primary human oligodendrocyte cultures isolated from white matter medically intractable epilepsy patients. Cultures at isolation contained 84% mature oligodendrocytes 16% progenitor cells (OPC). The two populations showed a protracted membranes expressing myelin proteins after 2–3 weeks culture, were kept...

10.1002/glia.21163 article EN Glia 2011-03-28

Despite tremendous progress in characterizing the myriad cellular structures nervous system, a full appreciation of interdependent and intricate interactions between these is as yet unfulfilled. Indeed, few more so than interaction myelin internode its ensheathed axon. More half-century after ultrastructural characterization this axomyelin unit, we lack reliable understanding physiological properties, significance consequence pathobiological processes, means to gauge success or failure...

10.1080/17590914.2024.2447336 article EN cc-by-nc ASN NEURO 2025-01-30

Multiple sclerosis (MS) is characterized by inflammation within the CNS. This inflammatory response associated with production of nitric oxide (NO) and NO-related species that nitrosylate thiols. We postulated MS patients would exhibit an antibody (Ab) directed against proteins containing S-nitrosocysteine (SNO-cysteine) showed anti-NO-cysteine Abs IgM isotype are in fact present sera some (Boullerne et al., 1995). report here presence a seemingly identical Ab SNO-cysteine acute model MS,...

10.1523/jneurosci.22-01-00123.2002 article EN cc-by-nc-sa Journal of Neuroscience 2002-01-01

Abstract : Nitric oxide (NO) produced in inflammatory lesions may play a major role the destruction of oligodendrocytes multiple sclerosis and experimental allergic encephalomyelitis. The transformed murine oligodendroglial line N20.1 is much more resistant than primary to killing by NO generator S ‐nitroso‐ N ‐acetyl‐DL‐penicillamine (SNAP). This observation prompted investigation mechanisms leading cell death cells comparison SNAP with another donor, sodium nitroprusside (SNP). We observed...

10.1046/j.1471-4159.1999.0721050.x article EN Journal of Neurochemistry 1999-03-01

Active nitrogen species are overproduced in inflammatory brain lesions multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). NO has been shown to mediate the death of oligodendrocytes (OLs), a primary target damage MS. To develop strategies protect OLs, we examined mechanisms cytotoxicity two donors, S-nitroso-N-acetyl-penicillamine (SNAP) sodium nitroprusside (SNP) on mature mouse OLs. Nitrosonium ion (NO+) rather than · mediates with both SNAP SNP, as by significant...

10.1002/1097-4547(20010115)63:2<124::aid-jnr1004>3.0.co;2-c article EN Journal of Neuroscience Research 2001-01-01

In EAE (experimental autoimmune encephalomyelitis), agonists of PPARs (peroxisome proliferator-activated receptors) provide clinical benefit and reduce damage. contrast with PPARγ, PPARδ are more effective when given at later stages increase myelin gene expression, suggesting effects on OL (oligodendrocyte) maturation. the present study we examined agonist GW0742 OPCs (OL progenitor cells), tested whether involve modulation BMPs (bone morphogenetic proteins). We show that mediated through...

10.1042/an20090033 article EN cc-by-nc ASN NEURO 2009-12-10

We identified a family in which five siblings were diagnosed with multiple sclerosis (MS) or clinically isolated syndrome. Several women the maternal lineage have comorbidities typically associated Peutz Jeghers Syndrome, rare autosomal-dominant disease caused by mutations serine-threonine-kinase 11 (STK11) gene, encodes liver kinase B1. Sequence analysis of DNA from one sibling single-nucleotide polymorphism (SNP) within STK11 intron 5. This SNP (dbSNP ID: rs9282860) was TaqMan polymerase...

10.1177/1759091415568914 article EN cc-by ASN NEURO 2015-02-01

Abstract The most commonly used immunogen to induce experimental autoimmune encephalomyelitis is MOG 35‐55 , a 21‐residue peptide derived from myelin oligodendrocyte glycoprotein (MOG). In studies, mice exhibit chronic disease; however, in some studies show transient disease. One variable that not often controlled for the fraction of purified material, which can vary less than 50% over 90%, with remainder mass primarily comprised counter ion purification. We compared development clinical...

10.1111/jnc.12664 article EN Journal of Neurochemistry 2014-01-28

Abstract Liver kinase B1 (LKB1) is a ubiquitously expressed involved in the regulation of cell metabolism, growth, and inflammatory activation. We previously reported that single nucleotide polymorphism gene encoding LKB1 risk factor for multiple sclerosis (MS). Since astrocyte activation metabolic function have important roles regulating neuroinflammation neuropathology, we examined serine/threonine astrocytes chronic experimental autoimmune encephalomyelitis mouse model MS. To reduce LKB1,...

10.1002/glia.23742 article EN Glia 2019-10-30

Currently, the genetic variants strongly associated with risk for Multiple Sclerosis (MS) are located in Major Histocompatibility Complex. This includes DRB1*15:01 and DRB1*15:03 alleles at HLA-DRB1 locus, latter restricted to African populations; DQB1*06:02 allele HLA-DQB1 locus which is high linkage disequilibrium (LD) DRB1*15:01; protective A*02:01 HLA-A locus. HLA identification facilitated by co-inherited ('tag') single nucleotide polymorphisms (SNPs); however, SNP validation not...

10.1016/j.humimm.2024.110790 article EN cc-by-nc-nd Human Immunology 2024-04-04
Coming Soon ...